Metabolic Syndrome More Likely After Platinum-Based Chemotherapy for Testicular Cancer
Survivors of testicular cancer are more likely to develop metabolic syndrome after platinum-based chemotherapy.
Diagnosis & Disease Information
Insurance Status Linked to Survival in Patients With Testicular Cancer
Patients without insurance and those with Medicaid have an increased risk of presenting with advanced testicular cancer and cancer-related death compared with those who have insurance.
Radiation Therapy Better Than Chemotherapy for Stage IIA Testicular Cancer
Patients with stage IIA testicular cancer gain a survival advantage from treatment with radiation therapy compared with chemotherapy.
Genetic Variants Indicate 10-fold Increased Risk of Testicular Cancer
A new study has uncovered four new genetic variants associated with increased risk of testicular cancer. Testing for these and all 21 previously identified variants using genetic sequencing identified men at higher risk of testicular cancer.
New Test Predicts Relapse of Testicular Cancer
Scientists have developed a test that assesses 3 features of nonseminomatous germ cell tumor, a common kind of testicular cancer, to identify those patients at greatest risk of relapse.
Testicular cancer survivors may have increased fatigue
Recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.
Chemo testicular nonseminoma may increase risk of short-term CVD death
Patients with testicular nonseminoma have significantly increased cardiovascular disease mortality after chemotherapy.
Infertile men at a greater risk for all cancers
Compared with the vasectomy and control groups, infertile men had a higher risk of testis cancer, non-Hodgkin lymphoma, and all cancers.
Muscle-building supplements may be associated with testicular cancer
Taking muscle-building supplements significantly increases likelihood of developing testicular cancer.
Men who have had testicular cancer are more likely to develop prostate cancer
A case-control study of close to 180,000 men suggests that the incidence of prostate cancer is higher among men with a history of testicular cancer (12.6%) than among those without a history of testicular cancer (2.8%). Men who have had testicular cancer were also more likely to develop intermediate- or high-risk prostate cancers. The study…
- Loading...
Loading...
Next post in Web Exclusives
Loading... 
Loading...